Management of ventricular arrhythmias: a trial-based approach
P J Welch1, R L Page, M H Hamdan
1Department of Internal Medicine, The University of Texas Southwestern Medical Center, Dallas, USA.
Insights
Sudden cardiac death, often caused by ventricular tachycardia (VT), affects many. Identifying high-risk patients with coronary artery disease is crucial for preventing fatal arrhythmias through risk stratification and targeted therapies.
Area of Science:
- Cardiology
- Electrophysiology
- Preventive Medicine
Background:
- Sudden cardiac death (SCD) causes ~300,000 US deaths annually, primarily due to ventricular tachycardia (VT) and fibrillation in coronary artery disease patients.
- Most SCD events occur before hospital arrival, necessitating research into high-risk patient identification and intervention.
Purpose of the Study:
- To discuss risk stratification and primary prevention strategies for sustained ventricular arrhythmias.
- To review secondary prevention trials and management options for patients with established sustained ventricular arrhythmias.
Main Methods:
- Review of clinical trials and risk factor identification for sudden cardiac death.
- Analysis of therapeutic measures for high-risk cardiovascular patients.
Main Results:
- Myocardial infarction history, depressed left ventricular function, and nonsustained VT are independent risk factors for arrhythmic death.
- Patients with prior sustained VT or SCD are a high-risk group requiring aggressive evaluation and treatment.
Conclusions:
- Effective risk stratification and primary prevention are vital for reducing SCD.
- Aggressive evaluation and treatment are essential for high-risk individuals, including those with a history of sustained VT or SCD.
Abstract:
Sudden cardiac death accounts for approximately 300,000 deaths annually in the U.S., and most of these are secondary to ventricular tachycardia (VT) and fibrillation in patients with coronary artery disease. Most patients with cardiac death die before reaching the hospital, which brought about a tremendous amount of research focused at identifying patients at high risk. Several trials were initiated to test the effectiveness of various therapeutic measures in these high-risk patients. A history of myocardial infarction, depressed left ventricular function and nonsustained VT have all been identified as independent risk factors for future arrhythmic death. Similarly, patients with a history of sustained VT or a history of sudden cardiac death are a high-risk group and should be aggressively evaluated and treated. The purpose of this article is to discuss risk stratification and primary prevention of sustained ventricular arrhythmias. We also review the recent secondary prevention trials and discuss the options available in the management of patients with sustained ventricular arrhythmias.
Related Concept Videos
01:28Mechanism of Cardiac Arrhythmias
01:29Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
01:30Dysrhythmias V: Evaluating Dysrhythmias
01:25Dysrhythmias VI: Management of Dysrhythmias
01:25Dysrhythmias VII: Nursing Management of Dysrhythmias
01:25ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias